Synthetic cannabinoids are a recreational drug that can cause toxicity with significant side effects.
Case
We report a 21-year-old incarcerated male with a delayed presentation of pneumothorax, pneumomediastinum, and pneumoperitoneum following synthetic cannabinoid use with altered mental status.
Discussion
This case not only highlights the need to consider pneumothorax when evaluating synthetic cannabinoid toxicity but it also emphasizes a vulnerable population (incarcerated individuals at risk for trauma, substance use disorders, and mental illness) who are at risk for delayed medical care and poor follow-up.
YoungRMolinaA. More than bargained for: Pneumomediastinum and subcutaneous emphysema associated with synthetic cannabinoid use. BMJ Case Rep. 2018;11(1):e228066.
2.
YoungJTHeffernanEBorschmannR, et al.Dual diagnosis of mental illness and substance use disorder and injury in adults recently released from prison: A prospective cohort study. Lancet Public Health. 2018;3(5):e237-e248.
3.
SungHE. Prevalence and risk factors of violence-related and accident-related injuries among state prisoners. J Correct Health Care. 2010;16(3):178-187.
4.
BryantMKTatebeLCSivaNR, et al.Outcomes after emergency general surgery and trauma care in incarcerated individuals: an EAST multi-center study. Journal of Trauma and Acute Care Surgery. 2022;93(1):75-83.
